Bulletin
Investor Alert

New York Markets Close in:

Ensysce Biosciences Inc.

NAS: ENSC

GO
/marketstate/country/us

Market open

 --Real time quotes

Jan 21, 2022, 12:48 p.m.

/zigman2/quotes/202092269/composite

$

2.43

Change

-0.36 -12.90%

Volume

Volume 311,957

Real time quotes

/zigman2/quotes/202092269/composite

Previous close

$ 2.79

$ 2.43

Change

-0.36 -12.90%

Day low

Day high

$2.40

$2.74

Open

52 week low

52 week high

$1.25

$23.99

Open
Sorry, there are no transactions available for this individual.

Officers and Executives

Dr. D. Lynn Kirkpatrick
President, Chief Executive Officer & Director
Dr. Jeffrey Millard
Chief Operating Officer
Mr. David Humphrey
Chief Financial Officer
Dr. William K. Schmidt
Chief Medical Officer
Mr. Geoffrey Birkett
Chief Commercial Officer
Mr. David Tanzer
Vice President-Strategic Development
Mr. Richard Wright
Chief Business Officer
Dr. Linda Pestano
Chief Development Officer
Dr. Bob G. Gower
Chairman
Mr. Andrew K. Benton
Independent Director
Mr. William H. C. Chang
Independent Director
Dr. Adam S. Levin
Independent Director
Mr. Steven Robert Martin
Independent Director
Dr. Curtis Rosebraugh
Independent Director
Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.20%
  • /zigman2/quotes/201948298/composite BABA-5.69%
  • /zigman2/quotes/202092269/composite ENSC+36.10%
  • /zigman2/quotes/200164174/composite SNOA+74.50%
  • /zigman2/quotes/207683784/composite TIGR-10.38%
X
Powered by StockTwits
Link to MarketWatch's Slice.